Physician profile
James Perez
NPI 1770546301
$14,683.12
in general payments reported to CMS, 2019-2025
55 companies · $1,267 in 2025
The $1,267 reported for 2025 was more than what 88% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,775 · 2020: $1,880 · 2021: $2,699 · 2022: $2,001 · 2023: $2,205 · 2024: $1,856 · 2025: $1,267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,327.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,663.56 | 2019-2025 | Otezla, Repatha, Evenity |
| Novo Nordisk INC | $1,656.48 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $1,177.37 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Abbvie INC. | $1,107.71 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $991.95 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $943.24 | 2019-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Sanofi-Aventis U.S. LLC | $656.19 | 2019-2025 | |
| Lilly USA, LLC | $652.65 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $647.71 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $490.81 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $446.92 | 2019-2023 | Xarelto |
| Ironwood Pharmaceuticals, INC | $366.07 | 2019-2024 | Linzess |
| Amarin Pharma, INC. | $362.50 | 2019-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $303.37 | 2019-2024 | Xifaxan, Trulance, Cycloset |
| Merck Sharp & Dohme LLC | $261.58 | 2019-2023 | Verquvo |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $258.16 | 2019-2025 | |
| Dexcom, INC. | $246.27 | 2019-2025 | Dexcom G6 Transmitter |
| Ardelyx, INC. | $202.65 | 2023-2025 | Ibsrela |
| Kowa Pharmaceuticals America, INC. | $179.21 | 2022-2025 | Seglentis, Zoryve, Livalo |
| Medtronic, INC. | $165.18 | 2024 | Hawkone |
| Exact Sciences Corporation | $161.66 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Qiagen, LLC | $151.03 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $128.18 | 2019-2021 | |
| Genzyme Corporation | $120.51 | 2023-2024 | |
| Astellas Pharma US INC | $115.00 | 2019-2024 | Veozah, Myrbetriq |
| Vifor Pharma, INC. | $111.17 | 2020-2022 | |
| Mannkind Corporation | $103.53 | 2019-2023 | Afrezza |
| Otsuka America Pharmaceutical, INC. | $97.13 | 2023-2025 | Rexulti |
| Nestle Healthcare Nutrition INC. | $78.90 | 2021 | |
| Corcept Therapeutics | $66.88 | 2024-2025 | Korlym |
| Biogen, INC. | $65.69 | 2020-2023 | Spinraza |
| Radius Health, INC. | $65.54 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $62.67 | 2022-2025 | Eliquis |
| Allergan, INC. | $59.68 | 2020 | |
| Horizon Therapeutics Plc | $51.56 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $46.69 | 2019-2022 | |
| Althera Pharmaceuticals LLC | $44.07 | 2021-2022 | |
| Abbott Laboratories | $39.56 | 2023 | Freestyle Libre 2, Freestyle Libre 3 |
| Lundbeck LLC | $39.28 | 2024-2025 | Rexulti |
| Edwards Lifesciences Corporation | $30.34 | 2021 | |
| Daiichi Sankyo INC. | $27.50 | 2021-2022 | |
| Emmaus Medical, INC. | $25.49 | 2022 | |
| Medtronic Minimed, INC. | $21.33 | 2019 | |
| Sunovion Pharmaceuticals INC. | $19.56 | 2021 | |
| Vivus LLC | $18.00 | 2021 | |
| Agios Pharmaceuticals, INC. | $17.29 | 2025 | Pyrukynd |
| Hologic Sales and Service, LLC | $16.90 | 2025 | Aptima |
| Phathom Pharmaceuticals, INC. | $16.42 | 2025 | Voquezna |
| Cequr Corporation | $16.25 | 2024 | Cequr Simplicity |
| Biohaven Pharmaceutical Holding Company Ltd. | $15.00 | 2022 | |
| Verona Pharma, INC. | $14.88 | 2025 | Ohtuvayre |
| Scilex Pharmaceuticals INC. | $14.18 | 2019 | |
| Seqirus USA INC | $14.12 | 2019 | |
| Alexion Pharmaceuticals, INC. | $13.91 | 2023 | Strensiq |
| Esperion Therapeutics, INC. | $13.64 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.